Anti-E3 ubiquitin-protein ligase RNF213 antibody
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Polyclonal C17orf27 antibody. Suitable for IHC-P, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human RNF213 aa 200 to C-terminus.
View Alternative Names
ALO17, C17orf27, KIAA1554, KIAA1618, MYSTR, RNF213, E3 ubiquitin-protein ligase RNF213, ALK lymphoma oligomerization partner on chromosome 17, E3 ubiquitin-lipopolysaccharide ligase RNF213, Mysterin, RING finger protein 213
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-E3 ubiquitin-protein ligase RNF213 antibody (AB238677)
Paraffin-embedded human colon cancer tissue stained for RNF213 using ab238677 at 1/800 dilution in immunohistochemical analysis.
After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-E3 ubiquitin-protein ligase RNF213 antibody (AB238677)
A549 (human lung carcinoma cell line) cells stained for RNF213 (green) using ab238677 at 1/266 dilution in ICC/IF, followed by Alexa Fluor 488-congugated Goat Anti-Rabbit IgG (H+L) secondary antibody.
The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. Nuclear counterstain was DAPI (Blue).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-E3 ubiquitin-protein ligase RNF213 antibody (AB238677)
Paraffin-embedded human gastric cancer tissue stained for RNF213 using ab238677 at 1/800 dilution in immunohistochemical analysis.
After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RNF213 plays a significant function in vascular homeostasis and cellular stress response. It does not typically form part of a larger protein complex but interacts directly with its substrates during ubiquitination. Its activity is important for managing cellular processes linked to cell survival under various stress conditions. RNF213 modifies the stability and activity of proteins involved in these processes which supports proper vascular function and stress management.
Pathways
RNF213 plays a role in the autophagy and hypoxia-response pathways. Through these pathways RNF213 regulates proteins like hypoxia-inducible factor 1-alpha (HIF-1α) and other substrates that are integral to cellular response to low oxygen levels. This regulation contributes to cellular adaptation to stress conditions and affects pathways related to protein turnover and stress signal transduction.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Toxins 14: PubMed35050979
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com